Revvity, Inc.
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions s…
Medical - Diagnostics & Research
US, Waltham [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Revvity, Inc. (RVTY) to it's peer group, including competitors as well as it's industry.
All monetary values in mil. except volume - volume is in thousands.
Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diagnostics & Research Average | - - | - - | - - | 83,747.24 | 1,877.33 | 215.20 | 9,168.47 | 250.40 | 0.00 | -4.5456 | 0.19 | 0.4613 | -0.1384 | -0.02 | -0.17 | 2.2670 | - - | ||
Maximum | - - | - - | - - | 916,755.00 | 10,345.00 | 1,328.00 | 48,542.00 | 1,448.00 | 0.01 | 130.4121 | 3.48 | 0.7332 | 0.1877 | 0.01 | 0.03 | 6.8693 | - - | ||
Minimum | - - | - - | - - | 29.00 | 19.00 | -126.00 | -3,579.00 | -119.00 | 0.00 | -299.9607 | -1.63 | -0.0242 | -0.6824 | -0.07 | -1.68 | 0.7815 | - - | ||
Neogen Corporation NEOG | 14.58 | -0.32 -2.15% | 1,376 vs. 1,523 | 3,159.00 | 228.00 | -2.00 | -62.00 | 561.00 | -0.0093 | -460.3506 | 0.0000 | 0.5108 | -0.0088 | -0.0006 | -0.0004 | 2.1669 | 216.00 | ||
Laboratory Corporation of America Holdings LH | 240.17 | 2.32 0.98% | 302 vs. 580 | 20,087.00 | 3,176.00 | 228.00 | -163.00 | 8,055.00 | 2.7100 | 19.9507 | 0.0034 | 0.2636 | 0.0718 | 0.0286 | 0.0138 | 0.5844 | 83.00 | ||
Medpace Holdings, Inc. MEDP | 341.82 | 15.73 4.82% | 422 vs. 387 | 10,624.00 | 511.00 | 102.00 | 147.00 | -119.00 | 3.3200 | 29.9130 | 0.0000 | 0.3036 | 0.2007 | 0.1528 | 0.0571 | 0.7173 | 31.00 | ||
ICON Public Limited Company ICLR | 212.76 | 9.09 4.46% | 2,394 vs. 1,145 | 17,565.00 | 2,090.00 | 187.00 | 299.00 | 2,621.00 | 2.2700 | 36.5374 | 0.0000 | 0.2248 | 0.0897 | 0.0199 | 0.0110 | 1.1561 | 82.00 | ||
Agilent Technologies, Inc. A | 132.06 | 3.49 2.71% | 2,881 vs. 1,594 | 37,944.00 | 1,573.00 | 308.00 | 230.00 | 1,090.00 | 1.0500 | 32.5915 | 0.0017 | 0.5442 | 0.1958 | 0.0496 | 0.0284 | 1.4913 | 287.00 | ||
IDEXX Laboratories, Inc. IDXX | 418.55 | -0.06 -0.01% | 517 vs. 541 | 34,272.00 | 964.00 | 235.00 | 168.00 | 4,680.00 | 2.8400 | 46.9494 | 0.0000 | 0.6152 | 0.2444 | 0.1502 | 0.0702 | 1.0196 | 81.00 | ||
Charles River Laboratories International, Inc. CRL | 194.19 | 6.29 3.35% | 502 vs. 718 | 9,930.00 | 1,011.00 | 67.00 | 50.00 | 1,959.00 | 1.4200 | 51.7491 | 0.0000 | 0.3165 | 0.0666 | 0.0185 | 0.0083 | 1.1776 | 51.00 | ||
Revvity, Inc. RVTY | 111.11 | -0.23 -0.21% | 1,374 vs. 789 | 13,522.00 | 649.00 | 26.00 | 129.00 | 5,626.00 | 0.2100 | 122.5004 | 0.0007 | 0.4059 | 0.0400 | 0.0033 | 0.0019 | 1.6633 | 121.00 | ||
Mettler-Toledo International Inc. MTD | 1196.82 | 29.92 2.56% | 164 vs. 122 | 25,256.00 | 925.00 | 177.00 | 172.00 | 7,688.00 | 8.2800 | 40.4940 | 0.0000 | 0.5723 | 0.1917 | -1.1184 | 0.0541 | 0.6365 | 21.00 | ||
Waters Corporation WAT | 368.50 | 10.73 3.00% | 430 vs. 422 | 21,880.00 | 636.00 | 102.00 | 234.00 | 9,253.00 | 1.7300 | 49.8783 | 0.0000 | 0.5700 | 0.1605 | 0.0813 | 0.0227 | 1.1368 | 59.00 | ||
Syneos Health, Inc. SYNH | 42.98 | 0.01 0.02% | 6,703 vs. 1,323 | 4,457.00 | 1,366.00 | 0.00 | -51.00 | 96.00 | 0.0100 | 1386.2094 | 0.0000 | 0.2157 | 0.0006 | 0.0002 | 0.0001 | 1.0950 | 103.00 | ||
Qiagen N.V. QGEN | 42.33 | 0.24 0.57% | 960 vs. 1,213 | 9,390.00 | 458.00 | 80.00 | 94.00 | 2,486.00 | 0.3600 | 29.2114 | 0.0000 | 0.6283 | 0.1758 | 0.0224 | 0.0139 | 1.2067 | 221.00 | ||
IQVIA Holdings Inc. IQV | 197.60 | 3.22 1.66% | 1,858 vs. 1,427 | 35,864.00 | 3,740.00 | 288.00 | 377.00 | 4,980.00 | 1.5800 | 39.2964 | 0.0000 | 0.2759 | 0.0770 | 0.0454 | 0.0108 | 0.7810 | 181.00 |
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.